MEGHAN SULLIVAN, PHD
We are pleased to announce that Meghan Sullivan, PhD has joined the Science Team at PharmaWrite Medical Communications and MedVal Scientific Information Services as a reseacher and medical writer.
Dr. Sullivan received her PhD from The University of Chicago's committee on Molecular Pathology and Molecular Medicine, where her research focused on the production of cytokines in human pulmonary tissue and their contribution to asthma pathogenesis. While at The University of Chicago, Dr. Sullivan also studied the efficacy of the yearly influenza vaccine and its impact on the B-cell repertoire. Her extensive research in the field of human immunology makes her uniquely suited to working in the rapidly growing field of immuno-therapeutics.
Since graduating, Dr. Sullivan has been involved in numerous publications in the fields of oncology (glioblastoma, head and neck cancer, non-small–cell lung cancer, among others), diabetes, chronic kidney disease, cardiology, and rheumatology. In the field of oncology, she has extensive experience with immuno-oncologic agents, including monoclonal antibodies and small molecule inhibitors. She is a member of the International Society for Medical Publication Professionals and has received the Certified Medical Publication Professional certification. Her expertise includes the development of congress abstracts, posters, and presentations as well as original articles, reviews, gap analyses, and lexicons.
About PharmaWrite, LLC
PharmaWrite is a full-service medical communication company located in Princeton, New Jersey. We offer a comprehensive portfolio of services to the pharmaceutical and medical device industries. PharmaWrite's innovative and collaborative approach helps our clients meet their diverse prelaunch, launch, and post-launch challenges. With extensive experience in multiple therapeutic areas, our team of seasoned professionals can assist your company in publication planning and medical writing, scientific content development, and compliance and regulatory management. Our ability to deliver strategic scientific content within an integrated communications platform will ensure the desired results while exceeding your expectations.